Antizyme Inhibitor 1 Antikörper (AA 101-400) (Biotin)
Kurzübersicht für Antizyme Inhibitor 1 Antikörper (AA 101-400) (Biotin) (ABIN7144342)
Target
Alle Antizyme Inhibitor 1 (AZIN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-400
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Antizyme inhibitor 1 protein (101-400AA)
-
Isotyp
- IgG
-
-
anti-Antizyme Inhibitor 1 (AZIN1) (AA 5-290) antibody
AZIN1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Antizyme Inhibitor 1 (AZIN1) (AA 101-400) antibodyAZIN1 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Antizyme Inhibitor 1 (AZIN1) (AA 1-280) antibodyAZIN1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Antizyme Inhibitor 1 (AZIN1) (AA 1-448) antibodyAZIN1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Antizyme Inhibitor 1 (AZIN1) (AA 289-448) antibodyAZIN1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Antizyme Inhibitor 1 (AZIN1) (AA 339-447) antibodyAZIN1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1F11 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Antizyme Inhibitor 1 (AZIN1)
-
Andere Bezeichnung
- AZIN1
-
Hintergrund
-
Background: Antizyme inhibitor protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake by counteracting the negative effect of antizyme OAZ1, OAZ2 and OAZ3 on ODC1 activity (PubMed:17900240). Inhibits antizyme-dependent ODC degradation by binding to antizymes. Releases ODC1 from its inactive complex with antizymes, leading to formation of the catalytically active ODC1.
Aliases: Antizyme inhibitor 1 antibody, AZI antibody, Azin1 antibody, AZIN1_HUMAN antibody, OAZI antibody, OAZIN antibody, ODC1L antibody, Ornithine decarboxylase antizyme inhibitor antibody
-
UniProt
- O14977
Target
-
